Journals / Kırıkkale Üniversitesi Tıp Fakültesi Dergisi / 2021 / Cilt: 23 - Sayı: 2

Evaluation of Colistin Sensitivity in Samples Isolated From Blood in Intensive Care Units

YOĞUN BAKIM ÜNİTELERİNDE KANDAN İZOLE EDİLEN ÖRNEKLERDE KOLİSTİN DUYARLILIĞININ DEĞERLENDİRİLMESİ

Pages
385–394
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In our study, it was aimed to reveal the distribution of colistin resistance rates according to years in A. baumannii and P. aeruginosa strains.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Colistin is frequently used in infections caused by multi-drug resistant Acinetobacter baumannii and Pseudomonas aeruginosa, which cause infections resulting in mortality, especially in intensive care units.
📊
Key Findings & Data:Objective: Colistin is frequently used in infections caused by multi-drug resistant Acinetobacter baumannii and Pseudomonas aeruginosa, which cause infections resulting in mortality, especially in intensive care units.
💡
Conclusion & Impact:In our study, it was aimed to reveal the distribution of colistin resistance rates according to years in A. baumannii and P. aeruginosa strains.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:direnç · kan kültürü · kolistin

Abstract

Objective: Colistin is frequently used in infections caused by multi-drug resistant Acinetobacter baumannii and Pseudomonas aeruginosa, which cause infections resulting in mortality, especially in intensive care units. In our study, it was aimed to reveal the distribution of colistin resistance rates according to years in A. baumannii and P. aeruginosa strains.

Özet

Amaç: Özellikle yoğun bakım ünitelerinde mortalite ile sonuçlanan enfeksiyonlara neden olan çoklu ilaca dirençli Acinetobacter baumannii ve Pseudomonas aeruginosa’nın sebep olduğu enfeksiyonlarda kolistin sıklıkla kullanılmaktadır. Etkenlerin antimikrobiyal direnç profilleri hastaneden hastaneye hatta hastane içinde farklı üniteler arasında değişiklik gösterebilmektedir. Çalışmamızda izole edilen A. baumannii ve P. aeruginosa suşlarında kolistin direnç oranlarının yıllara göre dağılımını ortaya koymak amaçlanmıştır.

🔖

Cite This Article

KOCABAŞ, D., ÖZBEK, N., AYDIN, N. N., AKSOY, F., ÖZKAYA, E., YILMAZ, G., KÖKSAL, İ. (2021). Evaluation of Colistin Sensitivity in Samples Isolated From Blood in Intensive Care Units. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, Cilt: 23 - Sayı: 2, 385–394. https://ajindex.com/articles/343648

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Hanberger H, Arman D, Gill H, Jindrák V, Kalenic S, Kurcz A et al. Surveillance of microbial resistance in European Intensive Care Units: a first report from the Care-ICU programme for improved infection control. Intensive Care Med. 2009;35(1):91-100
  2. Sader HS, Farrell DJ, Flamm RK, Jones RN. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011). Diagn Microbiol Infect Dis. 2014;78(4):443-8
  3. Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther. 2013;11(3):297-308
  4. Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR. Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: A review. Front Microbiol. 2019;10:539
  5. Potron A, Poirel L, Nordmann P. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology. Int J Antimicrob Agents. 2015;45(6):568-585
  6. Lescat M, Poirel L, Jayol A, Nordmann P. Performances of the rapid polymyxin Acinetobacter and Pseudomonas tests for colistin susceptibility testing. Microb Drug Resist. 2019;25(4):520-3
  7. Antibiotic Resistance Threats in the United States, 2019. Centers for Disease Control and Prevention (CDC). Accessed date: 5 Janurary 2020:
  8. The detection and reporting of colistin resistance, 2018. World Health Organization (WHO). Accessed date: 5 Janurary 2020:
  9. Linden PK, Kusne S, Coley K, Fontes P, Kramer DJ, Paterson D. Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis. 2003;37(11):e154-60
  10. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 10.0, 2020. Accessed date: 5 Janurary 2020:
  11. Thabit AK, Crandon JL, Nicolau DP. Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials. Expert Opin Pharmacother. 2015;16(2) 159-77
  12. Wattal C, Raveendran R, Goel N, Oberoi JK, Rao BK. Ecology of blood stream infection and antibiotic resistance in intensive care unit at a tertiary care hospital in North India. Braz J Infect Dis. 2014;18(3):245-51
  13. Karaiskos I, Souli M, Galani I, Giamarellou H. Colistin: still a lifesaver for the